1. A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma. Issue 10 (26th August 2020) Authors: Kudo, Masatoshi; Morimoto, Manabu; Moriguchi, Michihisa; Izumi, Namiki; Takayama, Tetsuji; Yoshiji, Hitoshi; Hino, Keisuke; Oikawa, Takayoshi; Chiba, Tetsuhiro; Motomura, Kenta; Kato, Junko; Yasuchika, Kentaro; Ido, Akio; Sato, Takashi; Nakashima, Daisuke; Ueshima, Kazuomi; Ikeda, Masafumi; Okusa... Journal: Cancer science Issue: Volume 111:Issue 10(2020) Page Start: 3759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗